Final answer:
The priority nursing assessments for a woman receiving tocolytic therapy with terbutaline are monitoring the fetal heart rate, maternal pulse, and blood pressure, as well as maternal blood glucose levels.
Step-by-step explanation:
The priority nursing assessments for a woman receiving tocolytic therapy with terbutaline include monitoring the fetal heart rate, maternal pulse, and blood pressure. These assessments are essential due to the effects of terbutaline on both the mother and the fetus. Terbutaline, a beta-agonist, can cause maternal side effects such as tachycardia and hypotension, which necessitates close monitoring of vital signs. Moreover, the fetal heart rate should be assessed to ensure that the fetus is not experiencing distress as a consequence of the therapy.
Maternal blood glucose levels should also be closely monitored since terbutaline can increase blood sugar levels. Regular temperature checks are not typically the focus of terbutaline therapy unless there are signs of infection or water breakage. The odor of the amniotic fluid and maternal intake and output are also not usually a primary focus during tocolytic therapy, unless specific complications or concerns arise that would warrant these assessments.